Home Tags The Motely Fool

Tag: The Motely Fool

Everything you need to know about investing in Canadian marijuana stocks

9/27/18--The marijuana industry in Canada has exploded, with many Canadian marijuana stocks skyrocketing as well. What's going on now with marijuana in Canada? What threats exist for the marijuana industry? What are the best ways for investors to profit from the rapidly growing marijuana market? The Motley Fool presents everything you need to know about investing in Canadian marijuana stocks. Read

Marijuana stock GW Pharmaceuticals nabs DEA Schedule V

9/27/18--The Drug Enforcement Agency (DEA) has awarded GW Pharmaceuticals' epilepsy drug, Epidiolex, Schedule V status, its least restrictive classification. The decision clears the way for GW Pharmaceuticals to begin offering the only CBD oil that's cleared by the DEA for use nationwide, and it puts the company on a path to disrupt how doctors treat patients who fail to respond to existing anti-epilepsy medications. Read

4 niche marijuana stocks with massive market share

9/11/18--Marijuana stocks offering competitive advantages might prove attractive to investors. Throughout the industry, there are four such niche stocks that bring massive market share potential to the table: CannaRoyalty, Kush Bottles, GW Pharmaceuticals, and Innovative Industrial Properties. Read

Believe it or not, medical marijuana sales could fall

8/12/18--Based on the continued expansion of countries and states that allow legal medical marijuana, it may be assumed that global medical marijuana spending will keep on growing in 2018 like it has in previous years. However, Arcview Market Research and BDS Analytics project that global medical marijuana spending will drop by more than 19% year over year in 2018. Yet, medical marijuana sales are expected to increase again, and the growth rate over the next four years should be nearly as impressive as the period between 2014 and 2017. Read